BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27869377)

  • 21. Safety of Combination Laser or Intense Pulsed Light Therapies and Doxycycline for the Treatment of Rosacea.
    Schilling LM; Halvorson CR; Weiss RA; Weiss MA; Beasley KL
    Dermatol Surg; 2019 Nov; 45(11):1401-1405. PubMed ID: 31658188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rosacea Management: Update on general measures and topical treatment options.
    Schaller M; Schöfer H; Homey B; Hofmann M; Gieler U; Lehmann P; Luger TA; Ruzicka T; Steinhoff M
    J Dtsch Dermatol Ges; 2016 Dec; 14 Suppl 6():17-27. PubMed ID: 27869379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. State of the art: systemic rosacea management.
    Schaller M; Schöfer H; Homey B; Gieler U; Lehmann P; Luger TA; Ruzicka T; Steinhoff M
    J Dtsch Dermatol Ges; 2016 Dec; 14 Suppl 6():29-37. PubMed ID: 27869374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea.
    Neuhaus IM; Zane LT; Tope WD
    Dermatol Surg; 2009 Jun; 35(6):920-8. PubMed ID: 19397667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined treatment of recalcitrant papulopustular rosacea involving pulsed dye laser and fractional microneedling radiofrequency with low-dose isotretinoin.
    Kwon HH; Jung JY; Lee WY; Bae Y; Park GH
    J Cosmet Dermatol; 2020 Jan; 19(1):105-111. PubMed ID: 31102325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Erythematotelangiectatic Rosacea With Pulsed-Dye Laser and Oxymetazoline 1.0% Cream: A Retrospective Study.
    Suggs AK; Macri A; Richmond H; Munavalli G; Friedman PM
    Lasers Surg Med; 2020 Jan; 52(1):38-43. PubMed ID: 31709571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized split-face comparative study of long-pulsed alexandrite plus low-fluence Nd:YAG laser versus pulsed-dye laser in the treatment of rosacea.
    Park S; Lee JH; Kang E; Kim H; Kim JY; Lee EJ; Bae YJ; Kim J; Oh SH
    Lasers Surg Med; 2022 Nov; 54(9):1217-1225. PubMed ID: 36183378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Objective and quantitative improvement of rosacea-associated erythema after intense pulsed light treatment.
    Mark KA; Sparacio RM; Voigt A; Marenus K; Sarnoff DS
    Dermatol Surg; 2003 Jun; 29(6):600-4. PubMed ID: 12786702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of early-stage erythematotelangiectatic rosacea with a Q-switched 595-nm Nd:YAG laser.
    Goo BL; Kang JS; Cho SB
    J Cosmet Laser Ther; 2015 Jun; 17(3):139-42. PubMed ID: 25549817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Split-face randomized treatment of facial telangiectasia comparing pulsed dye laser and an intense pulsed light handpiece.
    Tanghetti EA
    Lasers Surg Med; 2012 Feb; 44(2):97-102. PubMed ID: 22180317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of short-pulsed intense pulsed light and pulsed dye laser to treat rosacea.
    Kim BY; Moon HR; Ryu HJ
    J Cosmet Laser Ther; 2019 Aug; 21(5):291-296. PubMed ID: 30285506
    [No Abstract]   [Full Text] [Related]  

  • 32. Rationale for Use of Combination Therapy in Rosacea.
    Stein Gold L; Baldwin H; Harper JC
    J Drugs Dermatol; 2020 Oct; 19(10):929-934. PubMed ID: 33026776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractional 532-nm KTP diode laser and 595-nm pulsed dye laser in treatment of facial telangiectatic erythema.
    Nam CH; Kim MH; Hong SP; Park BC
    J Cosmet Dermatol; 2019 Jun; 18(3):783-787. PubMed ID: 29974643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Swiss S1 guideline for the treatment of rosacea.
    Anzengruber F; Czernielewski J; Conrad C; Feldmeyer L; Yawalkar N; Häusermann P; Cozzio A; Mainetti C; Goldblum D; Läuchli S; Imhof L; Brand C; Laffitte E; Navarini AA
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1775-1791. PubMed ID: 28833645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenese und Klinik der Rosazea als Schlüssel für eine symptomorientierte Therapie.
    Reinholz M; Ruzicka T; Steinhoff M; Schaller M; Gieler U; Schöfer H; Homey B; Lehmann P; Luger TA
    J Dtsch Dermatol Ges; 2016 Dec; 14 Suppl 6():4-16. PubMed ID: 27869378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of ferritin in pathogenesis of rosacea and its value in efficacy of 595 nm pulsed dye laser in treatment of different variants of rosacea: a clinical and immunohistochemical study.
    Elwan NM; Salah SM; Abdelsalam SF; Elfar NN
    J Cosmet Laser Ther; 2020 Apr; 22(3):130-136. PubMed ID: 32441163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rosacea: Diagnosis and Treatment.
    Oge' LK; Muncie HL; Phillips-Savoy AR
    Am Fam Physician; 2015 Aug; 92(3):187-96. PubMed ID: 26280139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Open-label study assessing the efficacy and tolerability of topical skin care and sun protection alone and in combination with intense pulsed light therapy.
    Deaver Peterson J; Katz TM
    J Cosmet Dermatol; 2019 Dec; 18(6):1758-1764. PubMed ID: 31017734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Controlled dermabrasion with a newly developed erbium-YAG-laser system. Report of preliminary experiences].
    Teikemeier G; Stein E
    Hautarzt; 1996 Jul; 47(7):530-2. PubMed ID: 8926169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rosacea management: A comprehensive review.
    Sharma A; Kroumpouzos G; Kassir M; Galadari H; Goren A; Grabbe S; Goldust M
    J Cosmet Dermatol; 2022 May; 21(5):1895-1904. PubMed ID: 35104917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.